Cargando…

Bombesin-Tethered Reactive Oxygen Species (ROS)-Responsive Nanoparticles for Monomethyl Auristatin F (MMAF) Delivery

Dolastatin derivatives, represented by monomethylauristatin E (MMAE), have been translated in clinic with a form of antibody–drug conjugate; however, their potential in nanoparticle systems has not been well established due to the potential risk of immature release of extremely high cytotoxic dolast...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jihoon, Kim, Jee Seon, Min, Kyung Hyun, Kim, Young-Hwa, Chen, Xiaoyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066503/ https://www.ncbi.nlm.nih.gov/pubmed/33805342 http://dx.doi.org/10.3390/bioengineering8040043

Ejemplares similares

Light-Activated Monomethyl Auristatin E Prodrug Nanoparticles for Combinational Photo-Chemotherapy of Pancreatic Cancer
por: Cho, In Kyung, et al.
Publicado: (2022)

Tumor-Specific Monomethyl Auristatin E (MMAE) Prodrug Nanoparticles for Safe and Effective Chemotherapy
por: Cho, Hanhee, et al.
Publicado: (2022)

New insight on the structural features of the cytotoxic auristatins MMAE and MMAF revealed by combined NMR spectroscopy and quantum chemical modelling
por: Johansson, Mikael P., et al.
Publicado: (2017)

Monomethyl Auristatin E Grafted-Liposomes to Target Prostate Tumor Cell Lines
por: Abawi, Ariana, et al.
Publicado: (2021)

Peripheral neuropathy associated with monomethyl auristatin E-based antibody-drug conjugates
por: Fu, Zhiwen, et al.
Publicado: (2023)

Pharmacokinetic and Metabolism Studies of Monomethyl Auristatin F via Liquid Chromatography-Quadrupole-Time-of-Flight Mass Spectrometry
por: Park, Min-Ho, et al.
Publicado: (2019)

Halogenation at the Phenylalanine Residue of Monomethyl Auristatin F Leads to a Favorable cis/trans Equilibrium and Retained Cytotoxicity
por: Sokka, Iris K., et al.
Publicado: (2021)

Whole-Body Pharmacokinetics and Physiologically Based Pharmacokinetic Model for Monomethyl Auristatin E (MMAE)
por: Chang, Hsuan Ping, et al.
Publicado: (2021)

Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy
por: Hingorani, Dina V., et al.
Publicado: (2022)

Activating Autophagy Enhanced the Antitumor Effect of Antibody Drug Conjugates Rituximab-Monomethyl Auristatin E
por: Wang, Yichen, et al.
Publicado: (2018)

Development and Properties of Valine-Alanine based Antibody-Drug Conjugates with Monomethyl Auristatin E as the Potent Payload
por: Wang, Yanming, et al.
Publicado: (2017)

Fibroblast Growth Factor 2 Conjugated with Monomethyl Auristatin E Inhibits Tumor Growth in a Mouse Model
por: Krzyscik, Mateusz A., et al.
Publicado: (2021)

A monomethyl auristatin E-conjugated antibody to guanylyl cyclase C is cytotoxic to target-expressing cells in vitro and in vivo
por: Gallery, Melissa, et al.
Publicado: (2018)

Synthesis and Biological Evaluation of RGD and isoDGR–Monomethyl Auristatin Conjugates Targeting Integrin α(V)β(3)
por: Raposo Moreira Dias, André, et al.
Publicado: (2019)

Purification and In Vitro Evaluation of an Anti-HER2 Affibody-Monomethyl Auristatin E Conjugate in HER2-Positive Cancer Cells
por: Damiani, Isabella, et al.
Publicado: (2021)

Cytotoxic Conjugates of Fibroblast Growth Factor 2 (FGF2) with Monomethyl Auristatin E for Effective Killing of Cells Expressing FGF Receptors
por: Krzyscik, Mateusz Adam, et al.
Publicado: (2017)

Lysosomal P-gp-MDR1 Confers Drug Resistance of Brentuximab Vedotin and Its Cytotoxic Payload Monomethyl Auristatin E in Tumor Cells
por: Liu-Kreyche, Peggy, et al.
Publicado: (2019)

Synthesis and Evaluation of a Monomethyl Auristatin E—Integrin α(v)β(6) Binding Peptide–Drug Conjugate for Tumor Targeted Drug Delivery
por: Davis, Ryan A., et al.
Publicado: (2023)

Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers
por: Zhou, Wei, et al.
Publicado: (2023)

Homozygous mutations in DZIP1 can induce asthenoteratospermia with severe MMAF
por: Lv, Mingrong, et al.
Publicado: (2020)

FGF2 Dual Warhead Conjugate with Monomethyl Auristatin E and α-Amanitin Displays a Cytotoxic Effect towards Cancer Cells Overproducing FGF Receptor 1
por: Świderska, Karolina Weronika, et al.
Publicado: (2018)

Radiolabeled Bombesin Analogs
por: Mansi, Rosalba, et al.
Publicado: (2021)

Homozygous SPAG6 variants can induce nonsyndromic asthenoteratozoospermia with severe MMAF
por: Xu, Chuan, et al.
Publicado: (2022)

Correction to: Homozygous SPAG6 variants can induce nonsyndromic asthenoteratozoospermia with severe MMAF
por: Xu, Chuan, et al.
Publicado: (2022)

Bombesin and bombesin antagonists: studies in Swiss 3T3 cells and human small cell lung cancer.
por: Woll, P. J., et al.
Publicado: (1988)

Role of the neuropeptide, bombesin, in bile secretion.
por: Cho, W. K.
Publicado: (1997)

Targeting prostate cancer with radiolabelled bombesins
por: Maina, Theodosia, et al.
Publicado: (2006)

Dual-Warhead Conjugate Based on Fibroblast Growth Factor 2 Dimer Loaded with α-Amanitin and Monomethyl Auristatin E Exhibits Superior Cytotoxicity towards Cancer Cells Overproducing Fibroblast Growth Factor Receptor 1
por: Nawrocka, Daria, et al.
Publicado: (2023)

Structural Basis of Microtubule Destabilization by Potent Auristatin Anti-Mitotics
por: Waight, Andrew B., et al.
Publicado: (2016)

The Role of Reactive Oxygen Species (ROS) in the Biological Activities of Metallic Nanoparticles
por: Abdal Dayem, Ahmed, et al.
Publicado: (2017)

Targeted Delivery of Auristatin-Modified Toxins to Pancreatic Cancer Using Aptamers
por: Kratschmer, Christina, et al.
Publicado: (2017)

Increasing the Potential of the Auristatin Cancer-Drug Family by Shifting the Conformational Equilibrium
por: Sokka, Iris K., et al.
Publicado: (2019)

Reactive‐Oxygen‐Species‐Responsive Drug Delivery Systems: Promises and Challenges
por: Saravanakumar, Gurusamy, et al.
Publicado: (2016)

Engineered Zn(II)-Dipicolylamine-Gold Nanorod Provides Effective Prostate Cancer Treatment by Combining siRNA Delivery and Photothermal Therapy
por: Min, Kyung Hyun, et al.
Publicado: (2017)

Evolution of Bombesin Conjugates for Targeted PET Imaging of Tumors
por: Zhang, Hanwen, et al.
Publicado: (2012)

Molecular recognition of itch-associated neuropeptides by bombesin receptors
por: Li, Changyao, et al.
Publicado: (2022)

Bombesins: A New Frontier in Hybrid Compound Development
por: Serafin, Pawel, et al.
Publicado: (2023)

Subcellular Reactive Oxygen Species (ROS) in Cardiovascular Pathophysiology
por: Aldosari, Sarah, et al.
Publicado: (2018)

Reactive Oxygen Species in Osteoclast Differentiation and Possible Pharmaceutical Targets of ROS-Mediated Osteoclast Diseases
por: Agidigbi, Taiwo Samuel, et al.
Publicado: (2019)

Patients with MMAF induced by novel biallelic CFAP43 mutations have good fertility outcomes after intracytoplasmic sperm injection
por: Ma, Jing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u4gue3g2c6b5nnt7s0bgimfcgr